Tumors of the pancreas, lungs, kidneys, esophagus, cervix, colon, and gastrointestinal tract benefit from aberrant STAT3 activity, which also enhances tumor cell survival and adds to the malignant phenotype. This evidence concerns the gene STAT3 and neoplasm.